Advertisement
News
Advertisement

Thermo Fisher buys TREK Diagnostic from Magellan Bioscience

Mon, 07/18/2011 - 7:48am
Mass High Tech: The Journal of New England Technology

Waltham-based instrumentation giant Thermo Fisher Scientific Inc. has purchased Ohio company TREK Diagnostic Systems for an undisclosed amount from its parent, Chelmsford’s Magellan Bioscience Inc., according to a press release.

TREK Diagnostic is a provider of microbiology testing products and related consumables, including blood culture, microorganism identification and antibiotic susceptibility testing (AST) products. The company reported full year revenue in 2010 of $34 million and has 150 employees.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading